Funding for this research was provided by:
Eli Lilly and Company
Received: 13 May 2020
Accepted: 6 August 2020
First Online: 28 August 2020
Ethics approval and consent to participate
: All study procedures were in accordance with ethical standards of the 1964 Helsinki Declaration and its later amendments, relevant laws, institutional guidelines, and approved by an institutional review board (Copernicus Group, Cary, NC, US; protocol #A4091073). Participant informed consent (written or verbal) was obtained as approved by the institutional review board.
: Not applicable.
: The study was sponsored by Pfizer and Eli Lilly and Company. EN Bush is an employee and shareholder of Eli Lilly and Company. L Abraham is an employee and shareholder of Pfizer. C Burbridge and J Randall are employees of Clinical Outcomes Solutions, who were paid contractors to Pfizer and Eli Lilly and Company in the development of this manuscript and for the study design, management and data analysis.